Presentation by the Federation of African Pharmaceutical Manufacturers Associations made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.

1. The AU Pharmaceutical Manufacturing Plan
for Africa (PMPA) Business Plan – Role of
the Africa-based Industry
Dr. Paul A. Lartey
Chairman
Federation of African Pharmaceutical Manufacturers Associations
CEO
LaGray Chemical Company

2. FEDERATION OF AFRICAN PHARMACEUTICAL
MANUFACTURERS ASSOCIATIONS
Launched, Addis Ababa, Jan 25,2013
Currently 3 regional associations
• Federation of East African
Pharmaceutical Manufacturers
• Southern African Generic Medicines
Association
• West African Pharmaceutical
Manufacturers Association
2

3. FAPMA
FAPMA
231 manufacturers
3

4. FAPMA – VISION:
To be a vibrant and self-sustaining
pharmaceutical manufacturing
industry in Africa by providing quality
and affordable medicines so as to
contribute to the reduction of disease
burden and promote economic
development of the continent.
4

5. PHARMACEUTICAL MANUFACTURING PLAN FOR
AFRICA
• African Union Heads of State mandate
Abuja July 2005
• Initial plan endorsed by Heads of State,
Accra July 2007
• Conf. of African Ministers of Industry
accepts sector in Accelerated Industrial
Development plan for Africa, Algiers
March 2011
• Plan endorsed by Conf. of African
Ministers of Health, May 2012
• Submission to Heads of State, Addis
Ababa, July 2012
5

6. VISION OF THE PMPA
To develop a competitive and
enduring integrated pharmaceutical
manufacturing industry in Africa,
able to respond to the continent’s
need for a secure and reliable
supply of quality, affordable,
accessible, safe and efficacious
medicines.
6

7. CORE OBJECTIVES OF THE PMPA
Support local pharmaceutical
manufacturing in Africa to:
 increase access to affordable
quality medicines
 ensure sustainable supply of
essential medicines
 improve public health outcomes
 promote industrial and economic
development
7

8. OBJECTIVES FAPMA
Promote excellence, facilitate
networking, disseminate information and
raise awareness on matters relating to the
pharmaceutical industry
Promote access to
safe, quality, efficacious medicines in
Africa
Strengthen the local production of
medicines in Africa
Facilitate economic growth through
development of a sustainable, selfsufficient and viable pharmaceutical
industry in Africa
8

9. FAPMA AND PMPA
• Alignment of objectives
• Participated in evolving the
PMPA
• Participated in development of
the Business Plan for
implementation
• Will be a strong partner in its
implementation
9

10. KEY CHALLENGES OF THE INDUSTRY IN
SUB SAHARAN AFRICA
 Capacity and skills shortages
 Poor quality and counterfeit drugs
 Facilities are not compliant with
international standards of GMP
 Weak regulatory framework
 Lack of technology or absence of
technology
 No market data
 Lack of partnership or linkages
10

11. Generic Solutions









Human capital development
Development of a GMP road map
Time limited incentives and other government support
Facilitation of access to affordable financing
Legislation and policy at regional and national levels
Technical assistance to MRAs
Establishment of business linkages platform
Assistance with formulations for TRIPs as incentive
Support for national regional and pan-African
manufacturers associations
 Developing options for market data collection
11

12. Enhancing market data
collection and facilitating
market access
Partnerships, collaboratns
and fostering business
linkages
Regulatory systems
Strengthening and
enforcement
Access to affordable finance
and time limited incentives
Access to products
and technology
HR development
BASIC FOUNDATION
Quality
Access  Availability
Affordability  Competitiveness
Sustainability  Self-reliance
Sound sector strategy
Policy coherence
12

13. ROLE OF FAPMA IN IMPLEMENTATION OF PMPA
 Support efforts of our members in:
− Step up facilities upgrading and staff development
for GMP compliance
− Developing capacity and technology to take
advantage of TRIPS flexibilities
 Advocate for support and incentives – governments to
honor commitments
 Support strengthening of MRAs and advocate for
harmonization
 Partner and collaborate with other stakeholders
13

14. SYNERGY THROUGH PARTNERSHIP
Development
Partners
Financial
institutions
AUC
NEPAD
AFRICA
BASED
OPEN FOR
Private PHARMACEUTICAL
MANUFACTURING
BUSINESS
Sector
Regulators
African
Governments